These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 2503041

  • 21. Role of thromboxane A2.
    Ambler J, Birch J, Maguire ED, Wallis RB.
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract] [Full Text] [Related]

  • 22. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
    Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
    [Abstract] [Full Text] [Related]

  • 23. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N, Mais DE, Halushka PV.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [Abstract] [Full Text] [Related]

  • 24. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH, Nichols R, Schmeling JW, Ramwell PW.
    Thromb Res; 1981 Sep 15; 23(6):521-32. PubMed ID: 6798707
    [No Abstract] [Full Text] [Related]

  • 25. Regulation of thromboxane receptor activation in human platelets.
    Murray R, FitzGerald GA.
    Proc Natl Acad Sci U S A; 1989 Jan 15; 86(1):124-8. PubMed ID: 2521385
    [Abstract] [Full Text] [Related]

  • 26. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
    Heinroth I, Block HU, Pönicke K, Förster W.
    Prostaglandins Leukot Med; 1983 Oct 15; 12(2):189-206. PubMed ID: 6139824
    [Abstract] [Full Text] [Related]

  • 27. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
    De Clerck F, Beetens J, de Chaffoy de Courcelles D, Vercammen E, Freyne E, Janssen PA.
    Prog Clin Biol Res; 1989 Oct 15; 301():567-72. PubMed ID: 2529556
    [No Abstract] [Full Text] [Related]

  • 28. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB, Leĭtin VL, Repin VS.
    Biull Eksp Biol Med; 1984 Nov 15; 98(11):563-6. PubMed ID: 6439262
    [Abstract] [Full Text] [Related]

  • 29. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization.
    Hatmi M, Rotilio D, Haye B, Antonicelli F, Joseph D, Vargaftig BB.
    Eur J Pharmacol; 1986 Dec 16; 132(2-3):219-28. PubMed ID: 3028837
    [Abstract] [Full Text] [Related]

  • 30. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH, Gabriel D, Prior G, Schillinger E.
    Biomed Biochim Acta; 1988 Dec 16; 47(10-11):S75-8. PubMed ID: 2470362
    [Abstract] [Full Text] [Related]

  • 31. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP.
    Basic Clin Pharmacol Toxicol; 2005 Sep 16; 97(3):162-7. PubMed ID: 16128910
    [Abstract] [Full Text] [Related]

  • 32. Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization.
    Hatmi M, Lussiana JP, Junien JL, Burke J, Vargaftig BB.
    Biochem Pharmacol; 1988 Feb 01; 37(3):481-9. PubMed ID: 2827688
    [Abstract] [Full Text] [Related]

  • 33. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA, Rao AK, Disa J.
    Biochem J; 1988 Jul 01; 253(1):255-62. PubMed ID: 2458717
    [Abstract] [Full Text] [Related]

  • 34. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets.
    Fonlupt P, Croset M, Lagarde M.
    Thromb Res; 1991 Jul 15; 63(2):239-48. PubMed ID: 1837628
    [Abstract] [Full Text] [Related]

  • 35. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK, Ullian ME, Halushka PV.
    J Pharmacol Exp Ther; 1992 Jul 15; 262(1):238-45. PubMed ID: 1378092
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
    Sato T, Nakao K, Hashizume T, Fujii T.
    Biochim Biophys Acta; 1987 Nov 12; 931(2):157-64. PubMed ID: 3663714
    [Abstract] [Full Text] [Related]

  • 37. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M, Mais DE, Morinelli TA, Hamanaka N, Oatis JE, Halushka PV.
    J Pharmacol Exp Ther; 1992 Aug 12; 262(2):632-7. PubMed ID: 1386885
    [Abstract] [Full Text] [Related]

  • 38. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 39. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
    Hatmi M, del Maschio A, Lefort J, de gaetano G, Vargaftig BB, Cerletti C.
    J Pharmacol Exp Ther; 1987 May 01; 241(2):623-7. PubMed ID: 3106620
    [Abstract] [Full Text] [Related]

  • 40. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
    Zehender H, Witte EC, Wolff HP, Patscheke H.
    Biochem Pharmacol; 1988 Feb 01; 37(3):491-5. PubMed ID: 2962585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.